N-Methylhistamine Test

If you have recurring flushing, hives, gut cramps, or unexplained reactions that feel allergic but never show up on standard allergy panels, this test offers a window into the chemistry behind those episodes. It measures a stable byproduct of histamine, the molecule your immune cells dump out during allergic and mast cell reactions.

Histamine itself disappears from blood within minutes, which is why timing a blood draw to a flare is nearly impossible. The metabolite captured here lingers in urine long enough to give you a usable read on how much histamine your body has been producing over hours, not seconds.

What This Test Actually Measures

The analyte is N-methylhistamine (NMH), also written as 1-methylhistamine. It is made when an enzyme called HNMT (histamine-N-methyltransferase) chemically modifies histamine to inactivate it. Because the enzyme is present in nearly every tissue, the urinary metabolite reflects whole-body histamine turnover rather than activity in any single organ.

Histamine comes mostly from mast cells and basophils, two immune cell types that store granules full of inflammatory chemicals and release them during allergic reactions, mast cell disorders, and certain gut conditions. A higher urinary metabolite generally points to more histamine being released and processed somewhere in your body.

Mast Cell Disorders

Mast cell activation syndrome (MCAS) is defined by severe, recurring symptoms (flushing, hives, low blood pressure, gut upset) driven by mast cell mediators. Urinary N-methylhistamine is one of the non-invasive markers used to support this diagnosis, alongside serum tryptase and other urinary mediators.

In a study of 257 people with mast cell activation disease, elevated urinary N-methylhistamine was found in roughly 22 out of 100 people with MCAS and 43 out of 100 in systemic mastocytosis. Used in isolation, it misses many cases. Combined with other mediators, sensitivity climbs significantly.

For mastocytosis specifically, an early study found that urinary histamine metabolites caught all 8 of 8 patients, while measuring histamine itself missed more than half. The metabolite is a more reliable signal than histamine because it integrates release over time rather than catching a fleeting spike.

Bone Marrow Burden in Systemic Mastocytosis

In people already diagnosed with mast cell disease, urinary N-methylhistamine tracks how much mast cell tissue has built up in the bone marrow. Levels above roughly 400 µg per gram of creatinine (about double the upper limit of normal) strongly associate with marrow findings of mastocytosis, atypical mast cells, and the c-KIT D816V mutation.

This is clinically useful because it gives you a non-invasive way to gauge disease burden without repeating a bone marrow biopsy.

Hereditary Alpha Tryptasemia

In people with severe mast cell symptoms, the ratio of basal serum tryptase to urinary N-methylhistamine helps identify hereditary alpha tryptasemia (HαT), a genetic trait that amplifies mast cell reactions. A tryptase-to-NMH ratio above 0.129 predicted HαT with 91.3% sensitivity and 85.6% specificity. This pattern can explain why some people have outsized mast cell symptoms despite seemingly normal individual markers.

Inflammatory Bowel Disease

Urinary N-methylhistamine is elevated in people with active Crohn's disease and ulcerative colitis, and correlates with both clinical and endoscopic disease activity. In a study of 147 IBD patients, the metabolite functioned as an integrative marker of gut inflammation, reflecting histamine release from mast cells lining the intestinal wall. Levels remain elevated even during clinically inactive Crohn's, suggesting smoldering low-grade activity that other markers can miss.

Osteoporosis Risk in Mastocytosis

In 157 people with indolent systemic mastocytosis, higher urinary N-methylhistamine independently associated with osteoporotic fractures and osteoporosis. The link makes sense biologically: mast cells release factors that drive bone breakdown, and people with higher histamine turnover appear to lose bone faster. If you have a mast cell disorder, this marker carries weight beyond the symptom log.

Histamine Intolerance

Counterintuitively, people with food-related histamine intolerance often have lower urinary 1-methylhistamine than healthy controls. This pattern likely reflects impaired histamine breakdown in the gut, often tied to low activity of an enzyme called DAO (diamine oxidase). The histamine stays around as the unmetabolized parent compound rather than getting converted to the urinary metabolite this test captures.

Why a Low Result Does Not Always Mean You Are Fine

This test does not have a simple "higher is bad, lower is good" interpretation. A high value points toward active mast cell release or inflammatory bowel disease. A low value in someone with symptoms can actually suggest histamine intolerance with impaired metabolism, where histamine accumulates because it cannot be broken down efficiently. The result needs to be read in the context of your symptoms and any companion tests you ordered alongside it.

Reference Ranges

There are no universally adopted adult reference ranges for urinary N-methylhistamine, and values shift with age. The most cited published values come from a study of 68 children using a radioimmunoassay, with results reported in micromoles of NMH per mole of creatinine (a way of normalizing for urine concentration). These are illustrative orientation, not a fixed target. Your lab will likely use a different assay, different units (often µg per gram of creatinine), and report its own age-adjusted ranges.

Source: Van Gysel et al., 1996, Journal of the American Academy of Dermatology. Values declined about 6.1% per year of age in healthy children. Compare your own results within the same lab over time for the most meaningful trend, rather than comparing across labs that use different assays.

Tracking Your Trend

A single urinary N-methylhistamine result is a snapshot of histamine activity at the time of collection. Because mast cell disorders are episodic, one normal value cannot rule out the condition, and one high value should not be the sole basis for a diagnosis. The marker is most useful when measured serially, especially around symptomatic episodes.

For people being worked up for suspected MCAS, mastocytosis, or active IBD, collect a baseline, retest during a symptomatic flare if possible, and recheck every 6 to 12 months once a pattern is established. People with known mast cell disease may benefit from more frequent monitoring (every 3 to 6 months) when adjusting therapy or evaluating bone marrow burden over time.

When Results Can Be Misleading

Several factors can shift a single reading without changing your underlying biology:

• Recent food intake: histamine-rich foods (aged cheese, cured meats, fermented foods, wine) can transiently raise urinary metabolite output. Standardize your diet for 24 to 48 hours before collection.
• Exercise: vigorous aerobic or resistance exercise has been shown to increase urinary 1-methylhistamine as part of normal blood vessel dilation responses. Avoid intense workouts in the 24 hours before testing.
• Antihistamine medication: in asthmatic children treated with azelastine, urinary N-methylhistamine decreased alongside symptom improvement. If you are taking H1 or H2 blockers, your result reflects suppressed histamine signaling, not your underlying activity.
• Incomplete urine collection: for 24-hour collections, missing any urine over the collection window will produce a falsely low result. Follow your lab's collection instructions precisely.

What to Do With an Abnormal Result

If your urinary N-methylhistamine is elevated and you have recurring mast cell symptoms, the next step is a fuller mast cell workup rather than acting on this single number. That typically includes a baseline serum tryptase, urinary leukotriene E4, urinary prostaglandin metabolites, and a CBC with differential. An allergist or immunologist familiar with mast cell disease is the right specialist to involve.

If your result is low but symptoms strongly suggest histamine reactions to food, the picture may be histamine intolerance rather than primary mast cell activation. A trial of a low-histamine diet, with or without DAO enzyme supplementation, is a reasonable next investigative step. If your result is elevated and you have gastrointestinal symptoms, an evaluation for inflammatory bowel disease (including fecal calprotectin and colonoscopy if indicated) deserves consideration.